Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure

5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure

US Patent 9868757 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Dematerialized instant lottery ticket system and method2023
17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure2023
17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure2023
17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure2023
Istaroxime-containing intravenous formulation for the treatment of acute heart f2023
Istaroxime-containing intravenous formulation for the treatment of acute heart f2023